National Cancer Institute; Notice of Meetings, 26441-26442 [2014-10608]

Download as PDF emcdonald on DSK67QTVN1PROD with NOTICES Federal Register / Vol. 79, No. 89 / Thursday, May 8, 2014 / Notices Place: Renaissance Mayflower Hotel, 1127 Connecticut Avenue NW., Washington, DC 20036. Contact Person: Miriam Mintzer, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Room 3108, Bethesda, MD 20892, 301–523–0646, mintzermz@csr.nih.gov. Name of Committee: Oncology 2— Translational Clinical Integrated Review Group; Basic Mechanisms of Cancer Therapeutics Study Section. Date: June 5, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Ritz Carlton Hotel, 1150 22nd Street NW., Washington, DC 20037. Contact Person: Lambratu Rahman Sesay, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6214, MSC 7804, Bethesda, MD 20892, 301–451– 3493, rahman-sesayl@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Cellular Signaling and Regulatory Systems Study Section. Date: June 5, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Torrance Marriott South Bay, 3635 Fashion Way, Torrance, CA 90503. Contact Person: Elena Smirnova, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5187, MSC 7840, Bethesda, MD 20892, 301–357– 9112, smirnove@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Nuclear and Cytoplasmic Structure/Function and Dynamics Study Section. Date: June 5, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Mayflower Park Hotel, 405 Olive Way, Seattle, WA 98101. Contact Person: David Balasundaram, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 20892, 301–435– 1022, balasundaramd@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Macromolecular Structure and Function C Study Section. Date: June 5, 2014. Time: 8:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: Kinzie Hotel, 20 W Kinzie St., Chicago, IL 60654. Contact Person: William A Greenberg, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4168, MSC 7806, Bethesda, MD 20892, (301) 435– 1726, greenbergwa@csr.nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Skeletal Muscle and Exercise Physiology Study Section. VerDate Mar<15>2010 16:18 May 07, 2014 Jkt 232001 Date: June 5–6, 2014. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Historic Inns of Annapolis, 58 State Circle, Annapolis, MD. Contact Person: Richard Ingraham, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4116, MSC 7814, Bethesda, MD 20892, 301–496– 8551, ingrahamrh@mail.nih.gov. Name of Committee: Immunology Integrated Review Group; Hypersensitivity, Autoimmune, and Immune-mediated Diseases Study Section. Date: June 5–6, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Crystal City Marriott, 1999 Jefferson Davis Highway, Arlington, VA 22202. Contact Person: Bahiru Gametchu, DVM, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4204, MSC 7812, Bethesda, MD 20892, 301–408– 9329, gametchb@csr.nih.gov. Name of Committee: Molecular, Cellular and Developmental Neuroscience Integrated Review Group; Molecular Neuropharmacology and Signaling Study Section. Date: June 5, 2014. Time: 8:00 a.m. to 7:00 p.m. Agenda: To review and evaluate grant applications. Place: Lorien Hotel & Spa, 1600 King Street, Alexandria, VA 22314. Contact Person: Deborah L Lewis, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4183, MSC 7850, Bethesda, MD 20892, 301–408– 9129, lewisdeb@csr.nih.gov. Name of Committee: Brain Disorders and Clinical Neuroscience Integrated Review Group; Aging Systems and Geriatrics Study Section. Date: June 5–6, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: The Allerton Hotel, 701 North Michigan Avenue, Chicago, IL 60611. Contact Person: James P Harwood, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7840, Bethesda, MD 20892, 301–435– 1256, harwoodj@csr.nih.gov. Name of Committee: Immunology Integrated Review Group; Cellular and Molecular Immunology—A Study Section. Date: June 5–6, 2014. Time: 8:30 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Sheraton Silver Spring, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: David B Winter, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4204, MSC 7812, Bethesda, MD 20892, 301–435– 1152, dwinter@mail.nih.gov. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 26441 Name of Committee: Genes, Genomes, and Genetics Integrated Review Group; Genomics, Computational Biology and Technology Study Section. Date: June 5–6, 2014. Time: 8:30 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: Westin Georgetown, 2350 M St. NW., Washington, DC 20010. Contact Person: Barbara J Thomas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2218, MSC 7890, Bethesda, MD 20892, 301–435– 0603, bthomas@csr.nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Medical Imaging Study Section. Date: June 5–6, 2014. Time: 7:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Crown Plaza St. Louis—Downtown, 200 N. Fourth Street, St. Louis, MO 631023. Contact Person: Xiang-Ning Li, MD, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5112, MSC 7854, Bethesda, MD 20892, 301–435– 1744, lixiang@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS). Dated: May 2, 2014. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–10492 Filed 5–7–14; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meetings Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the National Cancer Institute Clinical Trials and Translational Research Advisory Committee. The meetings will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Cancer Institute Clinical Trials and Translational Research Advisory Committee. E:\FR\FM\08MYN1.SGM 08MYN1 emcdonald on DSK67QTVN1PROD with NOTICES 26442 Federal Register / Vol. 79, No. 89 / Thursday, May 8, 2014 / Notices Date: June 18, 2014. Time: 4 p.m. to 5 p.m. Agenda: Review of the CTAC Small Cell Lung Cancer (SCLC) Working Group’s Report. Place: National Cancer Institute Shady Grove, Shady Grove, 9609 Medical Center Drive, 6 West—CCCT Huddle, Rockville, MD 20892 (Virtual Meeting). Go To: https://cbiit.webex.com/cbiit/ j.php?MTID=mb9db8379b9faf5ef42f384b4 69c5ebdb. Meeting Password—Tim@l1ne. Meeting Number—730 501 868. AUDIO CONNECTION 1. Provide your number when you join the meeting to receive a call back. Alternatively, you can call one of the following numbers: Dial In Number: 1– 240–276–6338. 2. Follow the instructions that you hear on the phone. Your Cisco Unified Meeting Place meeting ID: 730 501 868. Contact Person: Sheila A. Prindiville, MD, MPH, Director, Coordinating Center for Clinical Trials, National Institutes of Health, National Cancer Institute, Coordinating Center for Clinical Trials, 9609 Medical Center Drive Room 6W136, Rockville, MD 20850, 240–276–6173, prindivs@ mail.nih.gov. Name of Committee: Clinical Trials Strategic Planning Subcommittee, National Cancer Institute Clinical Trials and Translational Research Advisory Committee. Date: July 8, 2014. Time: 2 p.m. to 3 p.m. Agenda: Review the final report of the NCI National Clinical Trials Network Working Group. Place: National Cancer Institute Shady Grove, 6West CCCT Huddle Room, 9609 Medical Center Drive, Rockville, MD 20850 (Teleconference), 1–866–652–9542, Password: 4596704. Contact Person: Sheila A. Prindiville, MD, MPH, Director, Coordinating Center for Clinical Trials, National Institutes of Health, National Cancer Institute, 9609 Medical Center Drive Room 6W136 Rockville, MD 20850, 240–276–6173, prindivs@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where agendas and any additional information for the meetings will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) VerDate Mar<15>2010 16:18 May 07, 2014 Jkt 232001 Dated: May 5, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. Dated: May 5, 2014. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–10608 Filed 5–7–14; 8:45 am] [FR Doc. 2014–10602 Filed 5–7–14; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute on Aging; Notice of Closed Meetings National Institute of Mental Health; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors, National Institute of Mental Health. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the NATIONAL INSTITUTE OF MENTAL HEALTH, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Neuromuscular Interactions Influencing Sarcopenia. Date: June 10, 2014. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Elaine Lewis, Ph.D., Scientific Review Branch, National Institute on Aging, Gateway Building, Suite 2C212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7707, elainelewis@nia.nih.gov. Name of Committee: National Institute on Aging Special Emphasis Panel; Alzheimer’s Disease Drug Development. Date: June 18, 2014. Time: 10 a.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, Suite 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892. Contact Person: Alexander Parsadanian, Ph.D., Scientific Review Officer, National Institute on Aging, Gateway Building 2C/212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–496–9666, parsadaniana@ nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 Name of Committee: Board of Scientific Counselors, National Institute of Mental Health. Date: June 2–4, 2014. Time: 3:00 p.m. to 4:00 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: Hilton Washington/Rockville 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Jennifer E. Mehren, Ph.D., Executive Secretary, Division of Intramural Research Programs, National Institute of Mental Health, NIH, 35A Convent Drive, Room GE 412, Bethesda, MD 20892–3747, 301–496–3501, mehrenj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program No. 93.242, Mental Health Research Grants, National Institutes of Health, HHS) Dated: May 2, 2014. Carolyn A. Baum, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–10604 Filed 5–7–14; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\08MYN1.SGM 08MYN1

Agencies

[Federal Register Volume 79, Number 89 (Thursday, May 8, 2014)]
[Notices]
[Pages 26441-26442]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-10608]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meetings

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of meetings of the 
National Cancer Institute Clinical Trials and Translational Research 
Advisory Committee.
    The meetings will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.

[[Page 26442]]

    Date: June 18, 2014.
    Time: 4 p.m. to 5 p.m.
    Agenda: Review of the CTAC Small Cell Lung Cancer (SCLC) Working 
Group's Report.
    Place: National Cancer Institute Shady Grove, Shady Grove, 9609 
Medical Center Drive, 6 West--CCCT Huddle, Rockville, MD 20892 
(Virtual Meeting).
    Go To: https://cbiit.webex.com/cbiit/j.php?MTID=mb9db8379b9faf5ef42f384b469c5ebdb.
    Meeting Password--Tim@l1ne.
    Meeting Number--730 501 868.

AUDIO CONNECTION
    1. Provide your number when you join the meeting to receive a 
call back. Alternatively, you can call one of the following numbers: 
Dial In Number: 1-240-276-6338.
    2. Follow the instructions that you hear on the phone. Your 
Cisco Unified Meeting Place meeting ID: 730 501 868.

    Contact Person: Sheila A. Prindiville, MD, MPH, Director, 
Coordinating Center for Clinical Trials, National Institutes of 
Health, National Cancer Institute, Coordinating Center for Clinical 
Trials, 9609 Medical Center Drive Room 6W136, Rockville, MD 20850, 
240-276-6173, prindivs@mail.nih.gov.

    Name of Committee: Clinical Trials Strategic Planning 
Subcommittee, National Cancer Institute Clinical Trials and 
Translational Research Advisory Committee.
    Date: July 8, 2014.
    Time: 2 p.m. to 3 p.m.
    Agenda: Review the final report of the NCI National Clinical 
Trials Network Working Group.
    Place: National Cancer Institute Shady Grove, 6West CCCT Huddle 
Room, 9609 Medical Center Drive, Rockville, MD 20850 
(Teleconference), 1-866-652-9542, Password: 4596704.
    Contact Person: Sheila A. Prindiville, MD, MPH, Director, 
Coordinating Center for Clinical Trials, National Institutes of 
Health, National Cancer Institute, 9609 Medical Center Drive Room 
6W136 Rockville, MD 20850, 240-276-6173, prindivs@mail.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/ctac/ctac.htm, where 
agendas and any additional information for the meetings will be 
posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: May 5, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-10608 Filed 5-7-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.